ProfileGDS2971 / 1.2.20.7
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 39% 47% 20% 29% 53% 53% 44% 56% 52% 29% 37% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.12475339
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)0.016074247
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.432720
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.31983829
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.050815453
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.0062734653
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)-0.041657644
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.067839756
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.073829452
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.31758329
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.16107537
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.27453229